Fondaparinux Alternatives Compared
Fondaparinux | Xarelto | Eliquis |
|
---|
Fondaparinux | Xarelto (rivaroxaban) | Eliquis (apixaban) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Deep Vein Thrombosis, Pulmonary Embolism, Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis Prophylaxis after Abdominal Surgery, Deep Vein Thrombosis Prophylaxis after Hip... View more |
Prescription only
Xarelto limits the ability of the blood to clot and is effective at treating or preventing conditions where the risk of blood clotting is high (such as atrial fibrillation, DVT, PE); however, it may... View more |
Prescription only
Eliquis reduces the clotting ability of the blood and is used in the treatment and prevention of several medical conditions associated with blood clots. It does not require monitoring, and an... View more |
Related suggestions Deep Vein Thrombosis
Pulmonary Embolism
Deep Vein Thrombosis, Prophylaxis
Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery
|
|||||||||||||||||||||||
More about Fondaparinux | More about Xarelto (rivaroxaban) | More about Eliquis (apixaban) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Fondaparinux has an average rating of 9.1 out of 10 from a total of 9 ratings on Drugs.com. 89% of reviewers reported a positive effect, while 0% reported a negative effect. |
Xarelto has an average rating of 5.5 out of 10 from a total of 222 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 41% reported a negative effect. |
Eliquis has an average rating of 5.2 out of 10 from a total of 238 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: fondaparinux side effects in more detail. |
See also: Xarelto side effects in more detail. |
See also: Eliquis side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all fondaparinux prices |
View all Xarelto prices |
View all Eliquis prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Arixtra, Arixtra 10 mg/dose, Arixtra 5 mg/dose, Arixtra 7.5 mg/dose |
N/A |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
21 hours |
13 hours |
12 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 170 drugs are known to interact with fondaparinux:
|
A total of 376 drugs are known to interact with Xarelto:
|
A total of 385 drugs are known to interact with Eliquis:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
N/A |
December 28, 2012 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.